RTI Biologics (RTIX) Cuts FY10 Outlook
Tweet Send to a Friend
RTI Biologics (Nasdaq: RTIX) lowers its FY10 EPS guidance from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
